- Zacks•7 days ago
With second quarter earnings season drawing to a close, focus in back on pipeline and regulatory updates.
- TheStreet.com•9 days ago
Bernstein analysts say the impact of Bristol-Myers Squibb's (BMY) failed cancer drug trial will be "greater than many investors expect."
AVEO Pharmaceuticals, Inc. (AVEO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||0.96 x 4200|
|Ask||0.99 x 3600|
|Day's Range||0.95 - 1.00|
|52wk Range||0.82 - 1.57|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-3.96|
|Avg Vol (3m)||198,810|
|Dividend & Yield||N/A (N/A)|